Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The genetic architecture of ALS.

Literature DB >> 33130222

The genetic architecture of ALS.

Aleksey Shatunov¹, Ammar Al-Chalabi².

Abstract

Entities: Disease

Year: 2020 PMID： 33130222 DOI： 10.1016/j.nbd.2020.105156

Source DB: PubMed Journal: Neurobiol Dis ISSN： 0969-9961 Impact factor: 5.996

Keyword Cloud
Cited

× No keyword cloud information.

17 in total

Review 1. Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents.

Authors: Stephen A Johnson; Ton Fang; Fabiola De Marchi; Dylan Neel; Donatienne Van Weehaeghe; James D Berry; Sabrina Paganoni
Journal: Drugs Date: 2022-09-19 Impact factor: 11.431

Review 2. Prionoids in amyotrophic lateral sclerosis.

Authors: Philippe Gosset; William Camu; Cedric Raoul; Alexandre Mezghrani
Journal: Brain Commun Date: 2022-06-09

Review 3. Towards Understanding the Relationship Between ER Stress and Unfolded Protein Response in Amyotrophic Lateral Sclerosis.

Authors: Chenxuan Zhao; Yong Liao; Abdul Rahaman; Vijay Kumar
Journal: Front Aging Neurosci Date: 2022-06-15 Impact factor: 5.702

4. FUS-P525L Juvenile Amyotrophic Lateral Sclerosis and Intellectual Disability: Evidence for Association and Oligogenic Inheritance.

Authors: Orly Goldstein; Talya Inbar; Merav Kedmi; Mali Gana-Weisz; Beatrice Abramovich; Avi Orr-Urtreger; Vivian E Drory
Journal: Neurol Genet Date: 2022-07-06

Review 5. Role of SNAREs in Neurodegenerative Diseases.

Authors: Azzurra Margiotta
Journal: Cells Date: 2021-04-23 Impact factor: 6.600

6. Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes.

Authors: Marco Pagani; Adriano Chiò; Antonio Canosa; Andrea Calvo; Cristina Moglia; Rosario Vasta; Francesca Palumbo; Luca Solero; Francesca Di Pede; Sara Cabras; Vincenzo Arena; Grazia Zocco; Federico Casale; Maura Brunetti; Luca Sbaiz; Salvatore Gallone; Maurizio Grassano; Umberto Manera
Journal: Eur J Nucl Med Mol Imaging Date: 2022-01-25 Impact factor: 10.057

The genetic architecture of ALS.

Review 1. Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents.

Review 2. Prionoids in amyotrophic lateral sclerosis.

Review 3. Towards Understanding the Relationship Between ER Stress and Unfolded Protein Response in Amyotrophic Lateral Sclerosis.

4. FUS-P525L Juvenile Amyotrophic Lateral Sclerosis and Intellectual Disability: Evidence for Association and Oligogenic Inheritance.

Review 5. Role of SNAREs in Neurodegenerative Diseases.

6. Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes.

Review 7. Facilitations and Hurdles of Genetic Testing in Neuromuscular Disorders.

Review 8. Autophagy regulation by acetylation-implications for neurodegenerative diseases.

Review 9. Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis.

10. Reactive astrocytes in ALS display diminished intron retention.